GBAF Logo
Business

EU signs joint procurement deal for Eli Lilly COVID-19 treatment

Published by maria gbaf

Posted on September 22, 2021

1 min read

· Last updated: February 3, 2026

Add as preferred source on Google
Eli Lilly COVID-19 treatment agreement signed by EU - Global Banking & Finance Review
The image depicts the signing of a joint procurement contract by the EU for Eli Lilly's monoclonal antibody COVID-19 treatment, part of the EU's strategy to combat the pandemic.
Global Banking & Finance Awards 2026 — Call for Entries

EU Finalizes Procurement Deal for COVID-19 Treatment

BRUSSELS (Reuters) – The European Commission has signed a joint procurement contract with U.S. drugmaker Eli Lilly and Co for the supply of a monoclonal antibody treatment for COVID-19, the EU executive arm said in a statement on Tuesday.

The treatment is under review by the European Medicines Agency, it said, and 18 EU countries have signed up to the joint procurement for the purchase of enough to treat up to 220,000 patients.

The deal is part of a portfolio of five promising therapeutics announced by the Commission under the EU’s COVID-19 Therapeutics Strategy in June. It also includes treatments from GlaxoSmithKline Plc and Vir Biotechnology Inc, Regeneron Pharmaceuticals Inc and Celltrion HealthCare Co.

“We need to continue our work to prevent illness with vaccines and at the same time ensure that we can treat it with therapeutics,” EU Commissioner for Health Stella Kyriakides said.

(Reporting by Jan Strupczewski; Editing by Bill Berkrot)

Key Takeaways

  • The EU signed a contract with Eli Lilly for COVID-19 treatment.
  • The treatment is under review by the European Medicines Agency.
  • 18 EU countries are involved in the procurement.
  • The deal is part of the EU's COVID-19 Therapeutics Strategy.
  • Other companies involved include GlaxoSmithKline and Regeneron.

Frequently Asked Questions

What is the main topic?
The main topic is the EU's procurement deal with Eli Lilly for a COVID-19 treatment.
What is the EU's COVID-19 Therapeutics Strategy?
It is a strategy by the EU to secure promising COVID-19 treatments, including those from Eli Lilly and other companies.
How many EU countries are involved in the procurement?
18 EU countries have signed up for the joint procurement.

Related Articles

Image for Price Isn’t Everything: Payment Options a Deciding Factor for B2B Buyers in Europe

Price Isn’t Everything: Payment Options a Deciding Factor for B2B Buyers in Europe

Image for The Optionality Trap—Why Too Much Flexibility Is Slowing Business Decisions

The Optionality Trap—Why Too Much Flexibility Is Slowing Business Decisions

Image for Why More Choices Are Slowing Businesses Down

Why More Choices Are Slowing Businesses Down

Image for Why More Output Isn’t Translating Into Better Results

Why More Output Isn’t Translating Into Better Results

Image for The Reversibility Problem—Why Businesses Hesitate Even When They Know the Answer

The Reversibility Problem—Why Businesses Hesitate Even When They Know the Answer

Image for The Alignment Illusion—Why Companies Agree on Strategy but Fail in Execution

The Alignment Illusion—Why Companies Agree on Strategy but Fail in Execution

More from Business

Explore more articles in the Business category

Image for Attention Is the New Competitive Advantage
Attention Is the New Competitive Advantage
Image for The Quiet Strategy Separating Winning Businesses From the Rest
The Quiet Strategy Separating Winning Businesses From the Rest
Image for The One Habit That Separates Growing Businesses from the Rest
The One Habit That Separates Growing Businesses from the Rest
Image for The Overlooked Edge That Matters More Than Strategy
The Overlooked Edge That Matters More Than Strategy
Image for The Hidden Pattern Behind Business Success
The Hidden Pattern Behind Business Success
Image for The Power of Pricing: How Smart Pricing Strategies Drive Profitability and Growth
The Power of Pricing: How Smart Pricing Strategies Drive Profitability and Growth
Image for Why Customer Experience Now Defines Success
Why Customer Experience Now Defines Success
Image for The New Cost Playbook: Why Strategic Spending Matters More Than Cutting Costs
The New Cost Playbook: Why Strategic Spending Matters More Than Cutting Costs
Image for The Trust Economy: Why Credibility and Transparency Are Driving Business Success
The Trust Economy: Why Credibility and Transparency Are Driving Business Success
Image for The Hidden Profit Engine: Why Operational Efficiency Is Redefining Business Performance
The Hidden Profit Engine: Why Operational Efficiency Is Redefining Business Performance
Image for Built to Withstand: Why Resilience Is Now the Foundation of Sustainable Business Growth
Built to Withstand: Why Resilience Is Now the Foundation of Sustainable Business Growth
Image for The Agility Imperative: How Fast-Moving Businesses Are Outpacing the Competition
The Agility Imperative: How Fast-Moving Businesses Are Outpacing the Competition
View All Business Posts